A rare healthcare issue both parties agree on: A solution to Alzheimer’s that can’t wait

Bipartisan legislators introduced the ASAP Act to authorize Medicare coverage for FDA-approved blood-based biomarker tests aimed at the early detection of Alzheimer’s and other dementias.